Generex Biotechnology Announces Investor Conference Call Scheduled for Friday November 29, 2019 at 9:30 AM

NEXT STORY
Nucleic Acid Amplification Testing (NAAT) Market To Reach USD 4.549 Billion By 2026 | Reports And Data
PREV STORY
Valneva Announces Appointments of Two Leading Vaccine Experts to its Scientific Advisory Board
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Veru Announces Presentation of Phase 2 Study of Enobosarm — a Selective Androgen Receptor Targeting Agent in Metastatic AR+ER+HER2- Breast Cancer at 2021 ESMO Breast Cancer Congress

author_avatar
NASDAQ Market News

Immunovaccine to Highlight Clinical Data for Its Lead Candidate in Oral Presentation at 54th Annual Meeting of the American Society of Clinical Oncology

author_avatar
NASDAQ Market News

Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 7, 2019

author_avatar
NASDAQ Market News